Pfizer Sees Unusually Large Options Volume (PFE)
Shares of Pfizer (NYSE:PFE) saw unusually large options trading on Monday. Investors bought 29,371 call options on the company, ARN reports. This represents an increase of approximately 134% compared to the average daily volume of 12,551 call options.
A number of analysts have recently weighed in on PFE shares. Analysts at TheStreet reiterated a “buy” rating on shares of Pfizer in a research note to investors on Monday. Separately, analysts at Cowen and Company downgraded shares of Pfizer from an “outperform” rating to a “market perform” rating in a research note to investors on Friday. They now have a $34.00 price target on the stock. Finally, analysts at UBS AG downgraded shares of Pfizer from a “buy” rating to a “hold” rating in a research note to investors on Thursday. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and ten have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $31.78.
Shares of Pfizer (NYSE:PFE) traded down 0.49% during mid-day trading on Monday, hitting $30.54. 23,981,400 shares of the company’s stock traded hands. Pfizer has a 1-year low of $26.34 and a 1-year high of $32.50. The stock’s 50-day moving average is $30.94 and its 200-day moving average is $29.68. The company has a market cap of $197.9 billion and a price-to-earnings ratio of 8.47.
Pfizer (NYSE:PFE) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.02. The company had revenue of $12.64 billion for the quarter, compared to the consensus estimate of $12.69 billion. During the same quarter last year, the company posted $0.53 earnings per share. Pfizer’s revenue was down 2.4% compared to the same quarter last year. On average, analysts predict that Pfizer will post $2.18 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, March 4th. Shareholders of record on Friday, February 7th will be given a dividend of 0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 3.41%. The ex-dividend date of this dividend is Wednesday, February 5th. This is a positive change from Pfizer’s previous quarterly dividend of $0.24.
Pfizer Inc (NYSE:PFE) is a research-based, global biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.